Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Feb 20, 2019 8:22 PM EST Latest News February 11, 2019 Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) February 4, 2019 Gilead Sciences Announces 11 Percent Increase in First Quarter 2019 Dividend February 4, 2019 Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results View All Events Feb 4, 2019 at 4:30 PM EST Fourth Quarter 2018 Gilead Sciences Earnings Conference Call Jan 7, 2019 at 9:30 AM PST Gilead Sciences at the 37th Annual J.P. Morgan Healthcare Conference Nov 27, 2018 at 9:30 AM EST Gilead Sciences at the Evercore ISI HealthCONx Conference View All
